Aug 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S.
VIENNA (Reuters) -Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, according to two sources close to the company and LinkedIn ...
News comes after layoffs announced on Wednesday Other companies, US administration have scrapped home working Novo employees can still make individual arrangements COPENHAGEN, Sept 11 (Reuters) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback